Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

He-jing Wang

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Kidney International|September 24, 2010
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidismKatherine Wesseling-Perry, Renata C Pereira, Shobha Sahney, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 6, 2013
The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trialJustine Bacchetta, Katherine Wesseling-Perry, Beatriz Kuizon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccineRobert A Wascher, Donald L Morton, Christine Kuo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Reduction of serum hepcidin by hemodialysis in pediatric and adult patientsJoshua Zaritsky, Brian Young, Barbara Gales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapyMasaru Shinozaki, Steven J O'Day, Minoru Kitago, et al.
Journal of the American Society of Nephrology : JASN|June 10, 2005
Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterolsIsidro B Salusky, William G Goodman, Shobha Sahney, et al.
Journal of the National Cancer Institute|January 22, 2004
Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanomaBret Taback, Steven J O'Day, Peter D Boasberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastasesHiroya Takeuchi, Anton Bilchik, Sukamal Saha, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2009
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterolsKatherine Wesseling-Perry, G Chris Harkins, He-Jing Wang, et al.
Nutrition Journal|August 30, 2008
A controlled trial of protein enrichment of meal replacements for weight reduction with retention of lean body massLeo Treyzon, Steve Chen, Kurt Hong, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Kidney International|September 24, 2010
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidismKatherine Wesseling-Perry, Renata C Pereira, Shobha Sahney, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 6, 2013
The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trialJustine Bacchetta, Katherine Wesseling-Perry, Beatriz Kuizon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccineRobert A Wascher, Donald L Morton, Christine Kuo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Reduction of serum hepcidin by hemodialysis in pediatric and adult patientsJoshua Zaritsky, Brian Young, Barbara Gales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapyMasaru Shinozaki, Steven J O'Day, Minoru Kitago, et al.
Journal of the American Society of Nephrology : JASN|June 10, 2005
Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterolsIsidro B Salusky, William G Goodman, Shobha Sahney, et al.
Journal of the National Cancer Institute|January 22, 2004
Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanomaBret Taback, Steven J O'Day, Peter D Boasberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastasesHiroya Takeuchi, Anton Bilchik, Sukamal Saha, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2009
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterolsKatherine Wesseling-Perry, G Chris Harkins, He-Jing Wang, et al.
Nutrition Journal|August 30, 2008
A controlled trial of protein enrichment of meal replacements for weight reduction with retention of lean body massLeo Treyzon, Steve Chen, Kurt Hong, et al.
Pageof 8